GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » Days Sales Outstanding

Medical Developments International (ASX:MVP) Days Sales Outstanding : 67.51 (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medical Developments International Days Sales Outstanding?

Medical Developments International's average Accounts Receivable for the six months ended in Dec. 2024 was A$7.39 Mil. Medical Developments International's Revenue for the six months ended in Dec. 2024 was A$19.99 Mil. Hence, Medical Developments International's Days Sales Outstanding for the six months ended in Dec. 2024 was 67.51.

The historical rank and industry rank for Medical Developments International's Days Sales Outstanding or its related term are showing as below:

ASX:MVP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.83   Med: 83.79   Max: 97.78
Current: 62.75

During the past 13 years, Medical Developments International's highest Days Sales Outstanding was 97.78. The lowest was 48.83. And the median was 83.79.

ASX:MVP's Days Sales Outstanding is ranked better than
59.4% of 968 companies
in the Drug Manufacturers industry
Industry Median: 71.165 vs ASX:MVP: 62.75

Medical Developments International's Days Sales Outstanding declined from Dec. 2023 (82.34) to Dec. 2024 (67.51).


Medical Developments International Days Sales Outstanding Historical Data

The historical data trend for Medical Developments International's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International Days Sales Outstanding Chart

Medical Developments International Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.57 48.83 73.87 85.01 86.67

Medical Developments International Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.98 73.82 82.34 59.67 67.51

Competitive Comparison of Medical Developments International's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Developments International's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Medical Developments International's Days Sales Outstanding falls into.



Medical Developments International Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Medical Developments International's Days Sales Outstanding for the fiscal year that ended in Jun. 2024 is calculated as

Days Sales Outstanding (A: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (8.769 + 6.973) / 2 ) / 33.149*365
=7.871 / 33.149*365
=86.67

Medical Developments International's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (6.973 + 7.814) / 2 ) / 19.987*365 / 2
=7.3935 / 19.987*365 / 2
=67.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Developments International  (ASX:MVP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Medical Developments International Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Medical Developments International's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Medical Developments International Business Description

Traded in Other Exchanges
Address
4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International Headlines

From GuruFocus

Roundhill Announces Two Fund Closures

By PRNewswire PRNewswire 03-18-2022